Pharmaxis' IPO

Pharmaxis raised a round of funding on October 11, 2003. Investors include Public.

Pharmaxis (ASX:PXS) is a specialist pharmaceutical company committed to the research, development and commercialisation of human therapeutic products that address chronic respiratory and autoimmune di…

Articles about Pharmaxis' IPO: